about
eNOS polymorphisms as predictors of efficacy of bevacizumab-based chemotherapy in metastatic colorectal cancer: data from a randomized clinical trial.Assessment of DNA damage and telomerase activity in exfoliated urinary cells as sensitive and noninvasive biomarkers for early diagnosis of bladder cancer in ex-workers of a rubber tyres industry.First evidence of a large CHEK2 duplication involved in cancer predisposition in an Italian family with hereditary breast cancer.Discrepancies between VEGF -1154 G>A polymorphism analysis performed in peripheral blood samples and FFPE tissueDNA Methylation profiles as predictors of recurrence in non muscle invasive bladder cancer: an MS-MLPA approach.Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: preliminary data.Clinical and genetic factors related to cancer-induced bone pain and bone pain relief.Promoter methylation of tumor suppressor genes in pre-neoplastic lesions; potential marker of disease recurrence.Urine telomerase: an important marker in the diagnosis of bladder cancer.Detection of colorectal cancer by a quantitative fluorescence determination of DNA amplification in stoolGene mutation analysis in EGFR wild type NSCLC responsive to erlotinib: are there features to guide patient selection?EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximabPotential of telomerase expression and activity in cervical specimens as a diagnostic tool.Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone.Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: a single center study.miR-17-92a-1 cluster host gene (MIR17HG) evaluation and response to neoadjuvant chemoradiotherapy in rectal cancer.The current role of telomerase in the diagnosis of bladder cancer.Urinary biomarkers of non-muscle-invasive bladder cancer: current status and future potential.Circulating and stool nucleic acid analysis for colorectal cancer diagnosis.Targeting Chromatin-Mediated Transcriptional Control of Gene Expression in Non-Small Cell Lung Cancer Therapy: Preclinical Rationale and Clinical Results.Impact of Candidate Genetic Polymorphisms in Prostate Cancer: An Overview.Bone metastases detection by circulating biomarkers: OPG and RANK-L.Defining the cutoff value of MGMT gene promoter methylation and its predictive capacity in glioblastoma.RT-PCR determination of maspin and mammaglobin B in peripheral blood of healthy donors and breast cancer patients.Circulating AR copy number and outcome to enzalutamide in docetaxel-treated metastatic castration-resistant prostate cancer.Development and characterization of a monoclonal antibody directed against human telomerase reverse transcriptase (hTERT).Gastric GISTs: Analysis of c-Kit, PDGFRA and BRAF mutations in relation to prognosis and clinical pathological characteristics of patients - A GIRCG study.Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy.GSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic ImplicationsUrine cell-free DNA integrity as a marker for early prostate cancer diagnosis: a pilot study.Telomerase activity detected by quantitative assay in bladder carcinoma and exfoliated cells in urine.Urine Cell-Free DNA Integrity Analysis for Early Detection of Prostate Cancer Patients.Specific Biomarkers Are Associated with Docetaxeland Gemcitabine-Resistant NSCLC Cell Lines.Gene methylation in rectal cancer: predictive marker of response to chemoradiotherapy?Molecular determinations of EGFR and EML4-ALK on a single slide of NSCLC tissue.c-kit and SCF expression in normal and tumor breast tissue.Improved stool DNA integrity method for early colorectal cancer diagnosis.LOH 19q indicates shorter disease progression-free interval in low-grade oligodendrogliomas with EMP3 methylation.Free DNA and carcinoembryonic antigen serum levels: an important combination for diagnosis of colorectal cancer.Morphological and genetic heterogeneity in multifocal lung adenocarcinoma: The case of a never-smoker woman.
P50
Q30986269-31022C1A-B33F-4C9F-A86F-46EC57433D6FQ33615608-1E79D58C-332A-4B4E-9A68-CE2643A3E285Q33882010-BE863DC2-D8F0-4CCC-8D41-693C86280E31Q34158325-BD324E04-56C0-4117-8E05-421629A4FFD8Q34249360-9BFB93B7-8B73-4B4D-8EC4-A1D2C4FF302EQ34472904-E0B5BCB6-CE91-4471-B089-73AEDDD560FEQ34641014-933C06E7-483B-4B53-9326-9EACAACAEF28Q34762217-6F431C91-0B80-4717-8334-0B2D31528A45Q34770052-5E0F0306-83DF-4E23-A913-429672318141Q34928368-DA385818-48C0-4FB5-A0C8-10C85BCA1D93Q35016510-2B086381-D607-4546-BA64-240E9FCE8726Q35042323-4FBC32F3-87B9-4752-93D2-67FF9B4A0F7DQ35588988-65A0B95B-07B3-4CB4-AB8E-A0F33369D0CCQ35603660-C310303E-6A52-4F5B-BD82-78169297E1C9Q36116373-BB8A29D2-29C5-4FAA-8DA9-0716772C2295Q36900550-DB8D4ABB-A41A-4661-AE51-778FFD8B2A34Q37197686-5442B374-54D1-4C1D-BA6A-5DCB11EEA732Q38020241-E28FF033-12DD-4631-90FB-1960DC01BC38Q38191574-CE2926A2-35AB-46AE-A8C6-556EEBCBC70DQ38582589-27D9ABB7-1EDD-430E-A6DE-6FB33A203605Q38620751-601C72D0-CF3E-4884-8FDB-D0B00E9838B3Q39558983-174474FE-C31A-4EEA-AEA6-75BF815FD0E8Q39876681-35767CB7-A2F7-4BE0-AD86-532343AD3FB9Q40339709-3E983DC5-2317-42A3-8824-5C5E9C92422BQ40374954-53882450-7076-48AE-81A4-5162FEA93DD9Q40393061-04B74C45-3B87-4642-91A7-8F717FF54D1CQ40717804-1C80CFC4-4AE2-416C-B608-94CD66AB605BQ41015110-0EA2602D-0972-40DB-A6CB-D3234E52130DQ41339288-F11579A4-B7CB-4902-811F-7D6E4234DFBDQ41672565-E86FDF08-21F7-4AAA-9AF3-BCEA51FFB076Q42353172-449D5F1B-9CC2-41D2-88ED-31727816C4A0Q43169980-A9C1DAB8-C4A3-4EB3-9D4D-F369C1BA288CQ43217708-E0DD41C5-B1D4-4A9A-813F-0EB0A174FDABQ43524369-90D0CB3C-5641-4A0B-9E5C-3C1C2B047397Q43805944-9E4DD651-FD98-443C-AC59-4ABAA9215B65Q44784074-A7E82EBC-1A6C-477E-B357-4B2985F23238Q45075888-16868417-0FB8-4D20-B99A-868AA7BAF414Q48370416-29139A28-278A-4234-B34F-C2EEA792A976Q51927595-7B38BF24-3FCD-4B2D-BF67-863E5DE6AB62Q52983259-FD0DBD73-55C5-47CB-B106-1858583A73E9
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Daniele Calistri
@ast
Daniele Calistri
@en
Daniele Calistri
@es
Daniele Calistri
@fr
Daniele Calistri
@nl
Daniele Calistri
@sl
type
label
Daniele Calistri
@ast
Daniele Calistri
@en
Daniele Calistri
@es
Daniele Calistri
@fr
Daniele Calistri
@nl
Daniele Calistri
@sl
prefLabel
Daniele Calistri
@ast
Daniele Calistri
@en
Daniele Calistri
@es
Daniele Calistri
@fr
Daniele Calistri
@nl
Daniele Calistri
@sl
P106
P1153
55924598400
P21
P31
P496
0000-0002-5064-2023